Nakamura, T.; Bonnard, B.; Palacios-Ramirez, R.; Fernández-Celis, A.; Jaisser, F.; López-Andrés, N.
Biglycan Is a Novel Mineralocorticoid Receptor Target Involved in Aldosterone/Salt-Induced Glomerular Injury. Int. J. Mol. Sci. 2022, 23, 6680.
https://doi.org/10.3390/ijms23126680
AMA Style
Nakamura T, Bonnard B, Palacios-Ramirez R, Fernández-Celis A, Jaisser F, López-Andrés N.
Biglycan Is a Novel Mineralocorticoid Receptor Target Involved in Aldosterone/Salt-Induced Glomerular Injury. International Journal of Molecular Sciences. 2022; 23(12):6680.
https://doi.org/10.3390/ijms23126680
Chicago/Turabian Style
Nakamura, Toshifumi, Benjamin Bonnard, Roberto Palacios-Ramirez, Amaya Fernández-Celis, Frédéric Jaisser, and Natalia López-Andrés.
2022. "Biglycan Is a Novel Mineralocorticoid Receptor Target Involved in Aldosterone/Salt-Induced Glomerular Injury" International Journal of Molecular Sciences 23, no. 12: 6680.
https://doi.org/10.3390/ijms23126680
APA Style
Nakamura, T., Bonnard, B., Palacios-Ramirez, R., Fernández-Celis, A., Jaisser, F., & López-Andrés, N.
(2022). Biglycan Is a Novel Mineralocorticoid Receptor Target Involved in Aldosterone/Salt-Induced Glomerular Injury. International Journal of Molecular Sciences, 23(12), 6680.
https://doi.org/10.3390/ijms23126680